MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabres

EQS-News: MorphoSys AG


/ Key word: Conference





MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting...

Related Keywords

Chicago , Illinois , United States , Germany , Massachusetts , Planegg , Bayern , Boston , American , Kaitlyn Nealy , Thomas Biegi , Julia Neugebauer , American Society Of Clinical Oncology , Corporate Affairs , Nasdaq , Twitter , Lymphoma Society , Constellation Pharmaceuticals Inc , Linkedin , Sys To Present New Phase , Oral Presentation , Clinical Oncology , Efficacy Data , Combination With Ruxolitinib , Patients With , Advanced Solid Tumors , Vice President , Global Head , Markets ,